Section 3 - Supplementary Information

Financial Highlights


($ thousands)
Condensed Statement of Financial Position
At End of Year (March 31, 2009)
% Change 2009 2008
Assets
Total Assets 6% 173,486 164,129
Total 6% $173,486 $164,129
Liabilities
Total Liabilities -11% 969,750 1,094,681
Equity
Total Equity -14% -796,264 -930,552
Total 6% $173,486 $164,129



($ thousands)
Condensed Statement of Financial Position
At End of Year (March 31, 2009)
% Change 2009 2008
Expenses
Total Expenses 4% 3,607,649 3,461,753
Revenues
Total Revenues 1% 84,839 83,743
Net Cost of Operations 4% $3,522,810 $3,378,010

Refer to the full Statement of Management Responsibility for further details (www.hc-sc.gc.ca).

Assets by Type

Assets by Type

Total assets were $173.5M at the end of 2008-09, an increase of $9.3M over the previous year. The majority of the increase was due to the recognition of prepaid expenses. $11.2M of prepaid expenses was recorded this year to recognize the estimated balance of transfer payments for First Nations and Inuit Health program recipients at the end of the fiscal year.

Liabilities by Type

Liabilities by Type

Total liabilities were $969.8M at the end of 2008-09, a decrease of $124.9M over the previous year. $110M of the reduction in liability is due to the payment to the Mental Health Commission of Canada and a payment of $123M to Canada Health Infoway. Increases in liabilities were recognized for a change in estimate to employee severance benefits and accounts payable and accrued liabilities.

Expenses by Strategic Outcome

Expenses by Strategic Outcome

There was an increase in expenses of $144.8M in 2008-09 over 2007-08. This was due mainly to increases salaries and wages $130.8M, professional and special services $23.4M and, travel for non-insured health patient $10.2M. These increases were partially offset by a decrease in amortization expenses ($20.3M)

Revenues by Strategic Outcome

Revenues by Strategic Outcome

Health Canada receives most of its funding through annual Parliamentary appropriations. HC uses the Consolidated Revenue Fund (CRF) which is administered by the Receiver General for Canada. All cash received by the department is deposited to the CRF and all cash disbursements made by the department are paid from the CRF. HC does however generate revenue from program activities that support the above-noted Strategic Outcomes. HC's total revenue was $84.8M in 2008-09, an increase of $1.1M over 2007-08.

List of Supplementary Information Tables

All electronic supplementary information tables for the 2008-09 Departmental Performance Report can be found on the Treasury Board of Canada Secretariat's website.

Other Items of Interest - Advancing the Science Agenda 2008-2009

In response to the Strategic Policy Renewal, clear goals were established: to foster the integration of science and policy, an important departmental priority; to ensure horizontal leadership in the development of a solid evidence base into departmental policy and regulatory decision making. This leadership role includes continued support on key ministerial priorities such as: pharmaceuticals management, mental health and addictions, patient safety/infectious disease, children and seniors, obesity, and injury prevention.

Health Canada's Science and Technology (S&T) Strategy, released in late 2008, lays out a strategic direction for science within Health Canada providing a policy framework for science planning, priority setting and management.

The S&T Strategy provides a foundation for the Department to draft a Science Plan that will put the policy framework into action. The Science Plan will set out the manner in which the S&T Strategy will be implemented and establish science priorities over the next 5-10 years, to: strengthen the contribution of science on key departmental priorities and the links between science and policy; deal with laboratory and science infrastructure issues; and recruit and retain the human resources required to deliver on its mandate.

To ensure continuity and effectiveness of external science advice to the Minister, interactions between the Senior Management Board of Health Canada and the Science Advisory Board have been enhanced. The Board reviews specific scientific and regulatory issues and broader science policy issues with future implications such as: climate change and health; healthy living initiatives; pandemic planning; efficiency and effectiveness in health care; physician forecasting; and Chemicals Management Plan.

The Research Ethics Board (REB), an independent body of experts, continues to ensure that research involving humans that is funded or conducted by the Department meets the highest ethical standards. HC and PHAC have examined the feasibility and value of establishing a joint REB. Progress has been achieved on the development of a HC science integrity policy to strengthen the oversight and governance of departmental science and research. It is expected the policy will be completed in 2009-2010.

For the last 8 years, the Science Forum has been a major event on the Health Canada calendar, bringing together highly trained professionals from across the department to discuss cutting-edge science that will ultimately inform and support health policies, program and regulatory work.

Contributing to the Government of Canada's Northern Strategy, Health Canada developed a scoping paper outlining its priorities and interests in the context of the design of a High Arctic Research Station.

The Department will continue to pursue strategic partnerships and linkages with external partners/stakeholders.

Date modified: